nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—Night blindness—Varenicline—nicotine dependence	0.0332	0.0455	CcSEcCtD
Voriconazole—Splenomegaly—Varenicline—nicotine dependence	0.0282	0.0386	CcSEcCtD
Voriconazole—Drug hypersensitivity—Varenicline—nicotine dependence	0.0194	0.0266	CcSEcCtD
Voriconazole—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.0151	0.0206	CcSEcCtD
Voriconazole—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.015	0.0557	CbGpPWpGaD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0146	0.0543	CbGpPWpGaD
Voriconazole—Osteoporosis—Varenicline—nicotine dependence	0.014	0.0191	CcSEcCtD
Voriconazole—Gastric ulcer—Varenicline—nicotine dependence	0.0135	0.0184	CcSEcCtD
Voriconazole—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0126	0.0467	CbGpPWpGaD
Voriconazole—Psoriasis—Varenicline—nicotine dependence	0.0125	0.017	CcSEcCtD
Voriconazole—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.0117	0.0435	CbGpPWpGaD
Voriconazole—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0113	0.0421	CbGpPWpGaD
Voriconazole—Haematemesis—Varenicline—nicotine dependence	0.0113	0.0154	CcSEcCtD
Voriconazole—Suicidal ideation—Varenicline—nicotine dependence	0.0112	0.0153	CcSEcCtD
Voriconazole—Nystagmus—Varenicline—nicotine dependence	0.011	0.015	CcSEcCtD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0105	0.0388	CbGpPWpGaD
Voriconazole—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0104	0.0142	CcSEcCtD
Voriconazole—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0103	0.0384	CbGpPWpGaD
Voriconazole—Scotoma—Varenicline—nicotine dependence	0.0103	0.0141	CcSEcCtD
Voriconazole—Gingivitis—Varenicline—nicotine dependence	0.00997	0.0136	CcSEcCtD
Voriconazole—Mydriasis—Varenicline—nicotine dependence	0.00981	0.0134	CcSEcCtD
Voriconazole—Glycosuria—Varenicline—nicotine dependence	0.00966	0.0132	CcSEcCtD
Voriconazole—Endocrine disorder—Varenicline—nicotine dependence	0.00944	0.0129	CcSEcCtD
Voriconazole—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.0093	0.0345	CbGpPWpGaD
Voriconazole—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00909	0.0338	CbGpPWpGaD
Voriconazole—Chest discomfort—Varenicline—nicotine dependence	0.00884	0.0121	CcSEcCtD
Voriconazole—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00866	0.0119	CcSEcCtD
Voriconazole—FMO1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00825	0.0306	CbGpPWpGaD
Voriconazole—Pulmonary embolism—Varenicline—nicotine dependence	0.00783	0.0107	CcSEcCtD
Voriconazole—FMO1—Biological oxidations—CYP2A7—nicotine dependence	0.00777	0.0289	CbGpPWpGaD
Voriconazole—Abnormal dreams—Varenicline—nicotine dependence	0.00773	0.0106	CcSEcCtD
Voriconazole—Hyperkalaemia—Varenicline—nicotine dependence	0.00769	0.0105	CcSEcCtD
Voriconazole—FMO1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00767	0.0285	CbGpPWpGaD
Voriconazole—Influenza like illness—Varenicline—nicotine dependence	0.0076	0.0104	CcSEcCtD
Voriconazole—Photophobia—Varenicline—nicotine dependence	0.00735	0.0101	CcSEcCtD
Voriconazole—Dry eye—Varenicline—nicotine dependence	0.00723	0.00989	CcSEcCtD
Voriconazole—Oesophagitis—Varenicline—nicotine dependence	0.00715	0.00979	CcSEcCtD
Voriconazole—Mouth ulceration—Varenicline—nicotine dependence	0.00708	0.00968	CcSEcCtD
Voriconazole—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00703	0.0261	CbGpPWpGaD
Voriconazole—Hypertonia—Varenicline—nicotine dependence	0.00686	0.00939	CcSEcCtD
Voriconazole—Euphoric mood—Varenicline—nicotine dependence	0.00672	0.0092	CcSEcCtD
Voriconazole—Lymphadenopathy—Varenicline—nicotine dependence	0.00666	0.00911	CcSEcCtD
Voriconazole—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00641	0.0238	CbGpPWpGaD
Voriconazole—Deafness—Varenicline—nicotine dependence	0.00635	0.00869	CcSEcCtD
Voriconazole—Eczema—Varenicline—nicotine dependence	0.00632	0.00865	CcSEcCtD
Voriconazole—Eye pain—Varenicline—nicotine dependence	0.00629	0.00861	CcSEcCtD
Voriconazole—Renal failure acute—Varenicline—nicotine dependence	0.00615	0.00842	CcSEcCtD
Voriconazole—Libido decreased—Varenicline—nicotine dependence	0.00613	0.00838	CcSEcCtD
Voriconazole—Amnesia—Varenicline—nicotine dependence	0.00605	0.00828	CcSEcCtD
Voriconazole—Atrial fibrillation—Varenicline—nicotine dependence	0.00599	0.0082	CcSEcCtD
Voriconazole—Visual disturbance—Varenicline—nicotine dependence	0.00599	0.0082	CcSEcCtD
Voriconazole—FMO3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0059	0.0219	CbGpPWpGaD
Voriconazole—Arthritis—Varenicline—nicotine dependence	0.00585	0.008	CcSEcCtD
Voriconazole—Hypoglycaemia—Varenicline—nicotine dependence	0.00582	0.00797	CcSEcCtD
Voriconazole—Cerebrovascular accident—Varenicline—nicotine dependence	0.0058	0.00793	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00576	0.0214	CbGpPWpGaD
Voriconazole—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00568	0.00777	CcSEcCtD
Voriconazole—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00564	0.00771	CcSEcCtD
Voriconazole—FMO3—Biological oxidations—CYP2A7—nicotine dependence	0.00556	0.0206	CbGpPWpGaD
Voriconazole—Psychotic disorder—Varenicline—nicotine dependence	0.00555	0.00759	CcSEcCtD
Voriconazole—FMO3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00548	0.0204	CbGpPWpGaD
Voriconazole—Urinary retention—Varenicline—nicotine dependence	0.0054	0.00739	CcSEcCtD
Voriconazole—Liver function test abnormal—Varenicline—nicotine dependence	0.00524	0.00718	CcSEcCtD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00522	0.0194	CbGpPWpGaD
Voriconazole—Dry skin—Varenicline—nicotine dependence	0.00521	0.00713	CcSEcCtD
Voriconazole—Hypokalaemia—Varenicline—nicotine dependence	0.00517	0.00708	CcSEcCtD
Voriconazole—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00516	0.0191	CbGpPWpGaD
Voriconazole—Abdominal distension—Varenicline—nicotine dependence	0.00494	0.00676	CcSEcCtD
Voriconazole—Dysphagia—Varenicline—nicotine dependence	0.00491	0.00672	CcSEcCtD
Voriconazole—Erectile dysfunction—Varenicline—nicotine dependence	0.00452	0.00619	CcSEcCtD
Voriconazole—Photosensitivity reaction—Varenicline—nicotine dependence	0.00448	0.00613	CcSEcCtD
Voriconazole—Hyperglycaemia—Varenicline—nicotine dependence	0.00443	0.00606	CcSEcCtD
Voriconazole—Infestation NOS—Varenicline—nicotine dependence	0.00438	0.00599	CcSEcCtD
Voriconazole—Infestation—Varenicline—nicotine dependence	0.00438	0.00599	CcSEcCtD
Voriconazole—Depression—Varenicline—nicotine dependence	0.00437	0.00597	CcSEcCtD
Voriconazole—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00434	0.00594	CcSEcCtD
Voriconazole—Acute coronary syndrome—Varenicline—nicotine dependence	0.00432	0.00591	CcSEcCtD
Voriconazole—Myocardial infarction—Varenicline—nicotine dependence	0.00429	0.00587	CcSEcCtD
Voriconazole—Stomatitis—Varenicline—nicotine dependence	0.00427	0.00584	CcSEcCtD
Voriconazole—Conjunctivitis—Varenicline—nicotine dependence	0.00426	0.00582	CcSEcCtD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00423	0.0157	CbGpPWpGaD
Voriconazole—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00423	0.0157	CbGpPWpGaD
Voriconazole—Hepatobiliary disease—Varenicline—nicotine dependence	0.00414	0.00567	CcSEcCtD
Voriconazole—Epistaxis—Varenicline—nicotine dependence	0.00413	0.00565	CcSEcCtD
Voriconazole—Sinusitis—Varenicline—nicotine dependence	0.00411	0.00562	CcSEcCtD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0041	0.0152	CbGpPWpGaD
Voriconazole—Bradycardia—Varenicline—nicotine dependence	0.004	0.00548	CcSEcCtD
Voriconazole—Hypoaesthesia—Varenicline—nicotine dependence	0.00391	0.00535	CcSEcCtD
Voriconazole—Hallucination—Varenicline—nicotine dependence	0.00391	0.00535	CcSEcCtD
Voriconazole—Urinary tract disorder—Varenicline—nicotine dependence	0.00388	0.00531	CcSEcCtD
Voriconazole—Oedema peripheral—Varenicline—nicotine dependence	0.00387	0.0053	CcSEcCtD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00386	0.0143	CbGpPWpGaD
Voriconazole—Connective tissue disorder—Varenicline—nicotine dependence	0.00386	0.00529	CcSEcCtD
Voriconazole—Urethral disorder—Varenicline—nicotine dependence	0.00385	0.00527	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00384	0.0143	CbGpPWpGaD
Voriconazole—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00381	0.0142	CbGpPWpGaD
Voriconazole—Visual impairment—Varenicline—nicotine dependence	0.00379	0.00518	CcSEcCtD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00378	0.014	CbGpPWpGaD
Voriconazole—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00373	0.0138	CbGpPWpGaD
Voriconazole—Erythema multiforme—Varenicline—nicotine dependence	0.00372	0.00509	CcSEcCtD
Voriconazole—Eye disorder—Varenicline—nicotine dependence	0.00367	0.00503	CcSEcCtD
Voriconazole—Tinnitus—Varenicline—nicotine dependence	0.00366	0.00501	CcSEcCtD
Voriconazole—Cardiac disorder—Varenicline—nicotine dependence	0.00365	0.00499	CcSEcCtD
Voriconazole—Angiopathy—Varenicline—nicotine dependence	0.00357	0.00488	CcSEcCtD
Voriconazole—Immune system disorder—Varenicline—nicotine dependence	0.00355	0.00486	CcSEcCtD
Voriconazole—Mediastinal disorder—Varenicline—nicotine dependence	0.00354	0.00485	CcSEcCtD
Voriconazole—Chills—Varenicline—nicotine dependence	0.00353	0.00483	CcSEcCtD
Voriconazole—Arrhythmia—Varenicline—nicotine dependence	0.00351	0.0048	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00349	0.013	CbGpPWpGaD
Voriconazole—Mental disorder—Varenicline—nicotine dependence	0.00344	0.00471	CcSEcCtD
Voriconazole—Malnutrition—Varenicline—nicotine dependence	0.00342	0.00468	CcSEcCtD
Voriconazole—Erythema—Varenicline—nicotine dependence	0.00342	0.00468	CcSEcCtD
Voriconazole—Flatulence—Varenicline—nicotine dependence	0.00337	0.00461	CcSEcCtD
Voriconazole—Dysgeusia—Varenicline—nicotine dependence	0.00335	0.00459	CcSEcCtD
Voriconazole—Back pain—Varenicline—nicotine dependence	0.00331	0.00453	CcSEcCtD
Voriconazole—Muscle spasms—Varenicline—nicotine dependence	0.00329	0.0045	CcSEcCtD
Voriconazole—Vision blurred—Varenicline—nicotine dependence	0.00322	0.00441	CcSEcCtD
Voriconazole—Tremor—Varenicline—nicotine dependence	0.00321	0.00439	CcSEcCtD
Voriconazole—Ill-defined disorder—Varenicline—nicotine dependence	0.00317	0.00434	CcSEcCtD
Voriconazole—Anaemia—Varenicline—nicotine dependence	0.00316	0.00433	CcSEcCtD
Voriconazole—Agitation—Varenicline—nicotine dependence	0.00314	0.0043	CcSEcCtD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00313	0.0116	CbGpPWpGaD
Voriconazole—Angioedema—Varenicline—nicotine dependence	0.00313	0.00428	CcSEcCtD
Voriconazole—Malaise—Varenicline—nicotine dependence	0.00309	0.00422	CcSEcCtD
Voriconazole—Vertigo—Varenicline—nicotine dependence	0.00307	0.00421	CcSEcCtD
Voriconazole—Syncope—Varenicline—nicotine dependence	0.00307	0.0042	CcSEcCtD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00306	0.0114	CbGpPWpGaD
Voriconazole—Palpitations—Varenicline—nicotine dependence	0.00302	0.00414	CcSEcCtD
Voriconazole—Loss of consciousness—Varenicline—nicotine dependence	0.00301	0.00412	CcSEcCtD
Voriconazole—Cough—Varenicline—nicotine dependence	0.00299	0.00409	CcSEcCtD
Voriconazole—Convulsion—Varenicline—nicotine dependence	0.00296	0.00406	CcSEcCtD
Voriconazole—Hypertension—Varenicline—nicotine dependence	0.00295	0.00404	CcSEcCtD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00292	0.0108	CbGpPWpGaD
Voriconazole—Arthralgia—Varenicline—nicotine dependence	0.00291	0.00399	CcSEcCtD
Voriconazole—Chest pain—Varenicline—nicotine dependence	0.00291	0.00399	CcSEcCtD
Voriconazole—Myalgia—Varenicline—nicotine dependence	0.00291	0.00399	CcSEcCtD
Voriconazole—Anxiety—Varenicline—nicotine dependence	0.0029	0.00397	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00289	0.00396	CcSEcCtD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00288	0.0107	CbGpPWpGaD
Voriconazole—Discomfort—Varenicline—nicotine dependence	0.00288	0.00394	CcSEcCtD
Voriconazole—Dry mouth—Varenicline—nicotine dependence	0.00285	0.0039	CcSEcCtD
Voriconazole—Oedema—Varenicline—nicotine dependence	0.00279	0.00382	CcSEcCtD
Voriconazole—Infection—Varenicline—nicotine dependence	0.00277	0.0038	CcSEcCtD
Voriconazole—Shock—Varenicline—nicotine dependence	0.00275	0.00376	CcSEcCtD
Voriconazole—Nervous system disorder—Varenicline—nicotine dependence	0.00274	0.00375	CcSEcCtD
Voriconazole—Thrombocytopenia—Varenicline—nicotine dependence	0.00273	0.00374	CcSEcCtD
Voriconazole—Tachycardia—Varenicline—nicotine dependence	0.00273	0.00373	CcSEcCtD
Voriconazole—Skin disorder—Varenicline—nicotine dependence	0.00271	0.00371	CcSEcCtD
Voriconazole—Hyperhidrosis—Varenicline—nicotine dependence	0.0027	0.00369	CcSEcCtD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00266	0.00988	CbGpPWpGaD
Voriconazole—Anorexia—Varenicline—nicotine dependence	0.00266	0.00364	CcSEcCtD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00263	0.00975	CbGpPWpGaD
Voriconazole—Hypotension—Varenicline—nicotine dependence	0.00261	0.00357	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00254	0.00348	CcSEcCtD
Voriconazole—Insomnia—Varenicline—nicotine dependence	0.00253	0.00346	CcSEcCtD
Voriconazole—Dyspnoea—Varenicline—nicotine dependence	0.00249	0.00341	CcSEcCtD
Voriconazole—Somnolence—Varenicline—nicotine dependence	0.00248	0.0034	CcSEcCtD
Voriconazole—Dyspepsia—Varenicline—nicotine dependence	0.00246	0.00336	CcSEcCtD
Voriconazole—Decreased appetite—Varenicline—nicotine dependence	0.00243	0.00332	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00241	0.0033	CcSEcCtD
Voriconazole—Pain—Varenicline—nicotine dependence	0.00239	0.00327	CcSEcCtD
Voriconazole—Constipation—Varenicline—nicotine dependence	0.00239	0.00327	CcSEcCtD
Voriconazole—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00239	0.00886	CbGpPWpGaD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00237	0.00879	CbGpPWpGaD
Voriconazole—Feeling abnormal—Varenicline—nicotine dependence	0.0023	0.00315	CcSEcCtD
Voriconazole—Gastrointestinal pain—Varenicline—nicotine dependence	0.00228	0.00312	CcSEcCtD
Voriconazole—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00225	0.00835	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00222	0.00824	CbGpPWpGaD
Voriconazole—Urticaria—Varenicline—nicotine dependence	0.00222	0.00304	CcSEcCtD
Voriconazole—Body temperature increased—Varenicline—nicotine dependence	0.00221	0.00302	CcSEcCtD
Voriconazole—Abdominal pain—Varenicline—nicotine dependence	0.00221	0.00302	CcSEcCtD
Voriconazole—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00218	0.0081	CbGpPWpGaD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00216	0.00801	CbGpPWpGaD
Voriconazole—Hypersensitivity—Varenicline—nicotine dependence	0.00206	0.00282	CcSEcCtD
Voriconazole—Asthenia—Varenicline—nicotine dependence	0.002	0.00274	CcSEcCtD
Voriconazole—Pruritus—Varenicline—nicotine dependence	0.00198	0.0027	CcSEcCtD
Voriconazole—Diarrhoea—Varenicline—nicotine dependence	0.00191	0.00261	CcSEcCtD
Voriconazole—Dizziness—Varenicline—nicotine dependence	0.00185	0.00253	CcSEcCtD
Voriconazole—Vomiting—Varenicline—nicotine dependence	0.00178	0.00243	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00176	0.00655	CbGpPWpGaD
Voriconazole—Rash—Varenicline—nicotine dependence	0.00176	0.00241	CcSEcCtD
Voriconazole—Dermatitis—Varenicline—nicotine dependence	0.00176	0.00241	CcSEcCtD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00176	0.00652	CbGpPWpGaD
Voriconazole—Headache—Varenicline—nicotine dependence	0.00175	0.00239	CcSEcCtD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00173	0.00643	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00173	0.00641	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00166	0.00618	CbGpPWpGaD
Voriconazole—Nausea—Varenicline—nicotine dependence	0.00166	0.00227	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00164	0.00609	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00163	0.00604	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0016	0.00595	CbGpPWpGaD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00142	0.00528	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00133	0.00495	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—CYP2A7—nicotine dependence	0.00133	0.00494	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00126	0.00467	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00124	0.0046	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00122	0.00452	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00115	0.00426	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00113	0.0042	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CYP2A7—nicotine dependence	0.00095	0.00353	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000802	0.00298	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000756	0.00281	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000746	0.00277	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000385	0.00143	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.000373	0.00138	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000284	0.00106	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000278	0.00103	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000215	0.000798	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000196	0.000728	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000129	0.00048	CbGpPWpGaD
